Sangli (Maharashtra) [India], April 10 (ANI): Following the Maharashtra government's claim about the state facing a shortage of Covid-19 vaccine, Swabhimani Shetkari Saghtana (SSS) leader Raju Shetti on Friday warned the Central government to increase the vaccine supply to the state within a
New Delhi [India], March 27 (ANI): Pune-based Serum Institute of India CEO Adar Poonawalla on Saturday informed that the trials for 'Covovax', a vaccine developed by Novavax, have begun in India, and added that he is hoping the vaccine launch will take place by September this year.
Kabul [Afghanistan], March 9 (ANI): Afghanistan on Monday received 468,000 doses of COVID-19 vaccine 'Covishield' from the Serum Institute of India (SII).
New Delhi [India], March 4 (ANI): Bharat Biotech and Serum Institute of India (SII), the country's leading COVID-19 vaccine manufacturers, on Thursday submitted to the Delhi High Court that adequate capacity of vaccines were available for judicial staff, advocates and judges as frontline wor
New Delhi [India], March 4 (ANI): Taking suo-motu cognisance of demand for inclusion of all associated with judicial functioning as frontline workers, the Delhi High Court on Wednesday issued notice to Secretary, Principal Secretary of Ministry of Health and Family Welfare, and the Governmen
Abuja [Nigeria], March 2 (ANI): Nigeria on Tuesday received 3.92 million doses of COVID-19 vaccine 'Covishield' from the Serum Institute of India (SII).
Male [Maldives], February 28 (ANI): The Maldivian Health Emergency Operation Centre (HEOC) on Saturday informed that over 98,511 people have received the first dose of Indian-made Covishield vaccines manufactured by Serum Institute of India (SII), reported avas.mv.
Guatemala City [Guatemala], February 27 (ANI): Guatemala President Alejandro Giammattei has thanked Prime Minister Narendra Modi and India for providing 200,000 doses of the Covishield vaccine -- which is manufactured by the Serum Institute of India -- on Friday.
Colombo [Sri Lanka], February 23 (ANI): Sri Lankan cabinet has approved the purchase of 10 million doses of 'Made in India' AstraZeneca's COVID-19 vaccine from the Serum Institute of India (SII), local media reported.
New Delhi [India], February 21 (ANI): Pune-based Serum Institute of India CEO Adar Poonawalla requested the countries to 'be patient' as they await the Covishield supplies, adding that SII is trying to maintain a balance between the needs of India and the world.